1. Digitum: Repositorio Institucional de la Universidad de Murcia
  2. Investigación
  3. Artículos
Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1038/s41589-019-0278-6

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorTapia-Abellán, Ana-
dc.contributor.authorAngosto-Bazarra, Diego-
dc.contributor.authorMartínez-Banaclocha, Helios-
dc.contributor.authorTorre-Minguela, Carlos de-
dc.contributor.authorCerón-Carrasco, Jose P-
dc.contributor.authorPérez-Sánchez, Horacio-
dc.contributor.authorArostegui, Juan I-
dc.contributor.authorPelegrín Vivancos, Pablo-
dc.date.accessioned2025-01-20T12:46:32Z-
dc.date.available2025-01-20T12:46:32Z-
dc.date.issued2019-06-
dc.identifier.citationNature Chemical Biology, 2019, Vol. 15, pp. 60-564es
dc.identifier.issnPrint: 1552-4450-
dc.identifier.issnElectronic: 1552-4469-
dc.identifier.urihttp://hdl.handle.net/10201/148834-
dc.description© 2019, The Author(s), under exclusive licence to Springer Nature America, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted Manuscript version of a Published Work that appeared in final form in Nature Chemical Biology. To access the final edited and published work see https://doi.org/10.1038/s41589-019-0278-6es
dc.description.abstractNLRP3 is an innate immune sensor contributing to the development of different diseases including monogenic autoinflammatory syndromes, gout, atherosclerosis, and Alzheimer’s disease. The molecule sulfonylurea MCC950 is a NLRP3 inflammasome inhibitor with potential clinical utility. However, the mechanism of action of MCC950 remains unknown. Here, we characterize the mechanism of action of MCC950 in both wild-type and autoinflammatory-related NLRP3 mutants, demonstrating that MCC950 closes the ‘open’ conformation of active NLRP3.es
dc.formatapplication/pdfes
dc.format.extent37es
dc.languageenges
dc.publisherNature Research-
dc.relationThis work was supported by grants from the Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00174 to P.P.), the Ministerio de Economia, Industria y Competitividad–Fondo Europeo de Desarrollo Regional (project nos. SAF2017-88276-R to P.P. and CTQ2017-87974-R to H.P.-S.), Fundación Séneca (20859/PI/18 to P.P.), and the European Research Council (ERC-2013-CoG 614578 to P.P.).es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectNLRP3es
dc.subjectInflammationes
dc.subjectMCC950es
dc.subjectMechanism of actiones
dc.subjectAntiinflammatoryes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::615 - Farmacología. Terapéutica. Toxicología. Radiologíaes
dc.titleMCC950 closes the active conformation of NLRP3 to an inactive statees
dc.typeinfo:eu-repo/semantics/articlees
dc.relation.publisherversionhttps://www.nature.com/articles/s41589-019-0278-6es
dc.identifier.doihttps://doi.org/10.1038/s41589-019-0278-6-
dc.contributor.departmentDepartamento de Bioquímica y Biología Molecular B e Inmunología-
Aparece en las colecciones:Artículos

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
2019 MCC.pdfVersión aceptada del artículo5,55 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem Mostrar el registro PREMIS del ítem  Estadísticas


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons